Publications by authors named "Fernando Galanternik"

Claim this Profile
E
Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.
Siamak Daneshmand, Renata Zaucha, James W F Catto, Ben Tran, Viraj Master, Fernando Galanternik

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma.
Ray Manneh Kopp, Fernando Galanternik, Fabio A Schutz, Fabio Kater, Allan Ramos-Esquivel

JCO Glob Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the Current Role of Immunotherapy for Colon Cancer?
Fernando Galanternik, Gonzalo Recondo, Matías E Valsecchi, Martín Greco, Gonzalo Recondo

Rev Recent Clin Trials· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for Non-Small Cell Lung Cancer - Finally a Hint of Hope.
Gonzalo Recondo, Gonzalo Recondo, Fernando Galanternik, Martín Greco, Máximo de la Vega

Rev Recent Clin Trials· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine.
Gonzalo Recondo, Maximo de la Vega, Fernando Galanternik, Enrique Díaz-Cantón, Bernardo Amadeo Leone

Cancer Manag Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis